Frank Bi 毕然
Partner, Practice Head Corporate Transactions (Asia)
Hong Kong
Latest thinking
Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.
Latest news, deals and awards
Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.
-
Ashurst Perkins Coie advises Oaktree Capital on landmark Zhongji Innolight IPO
七月 30, 2026
Discover more -
Ashurst Perkins Coie advises on RIGOL Technologies' HK$1.14 billion Hong Kong IPO
七月 09, 2026
Discover more -
Ashurst Perkins Coie advises Oaktree Capital on US$20m cornerstone investment in Momenta Global Limited
七月 08, 2026
Discover more -
Ashurst advises on Hanx Biopharmaceuticals’ HK$586 million Hong Kong listing
十二月 23, 2025
Discover more -
Ashurst advises Xizang Zhihui Mining on $550 million Hong Kong IPO
十二月 19, 2025
Discover more -
Ashurst advises on Butong Group’s HK$781.84 million Hong Kong IPO
九月 23, 2025
Discover more -
Ashurst advises Home Control on the mandatory unconditional general cash offer by Meta-Wisdom
八月 05, 2025
Discover more -
Ashurst advises Home Control on the mandatory unconditional general cash offer by Meta-Wisdom
八月 05, 2025
Discover more -
Ashurst advises on China's biotech firm Cloudbreak Pharma’s Hong Kong IPO
七月 03, 2025
Discover more -
Ashurst advises on Chinese new energy solution provider Breton Technology's HK$234 million H-shares IPO
五月 08, 2025
Discover more